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TO THE EDITOR
Mitochondrial (mt) contribution to
carcinogenesis has been critically dis-
cussed with circumstantial evidence
against as well as for a causal role.
Proliferating cancer cells are dependent
on sufficient energy supply that would
argue against defective mitochondria in
tumor cells. On the other hand, mito-
chondria are the main endogenous
source of reactive oxygen species as
highly mutagenic side products of
oxidative phosphorylation (Fridovich,
2004) and increased amounts of
mtDNA mutations have been detected
in a variety of tumors (reviewed by
Berneburg et al., 2006).
One of the best described mt dele-
tions is the 4977 bp common deletion
(Cortopassi and Arnheim, 1990). The
common deletion affects several transfer
RNA and respiratory chain genes. It is
known to be involved in myopathies
(Holt et al., 1989), Alzheimer’s disease
(Corral-Debrinski et al., 1994), as well
as chronological aging, and photoaging
of the skin (Cortopassi and Arnheim,
1990; Berneburg et al., 1997; Berne-
burg et al., 1999). Generally, chron-
ological aged skin has an elevated level
Table 1. Age and localization of 20 patients with SCC (sun exposed: head and face and upper extremities; non-sun
exposed: trunk and lower extremities)
Patient
(number)
Age of patients
(years) Localization
Level of the common deletion (in tumor)
as percentage of total mtDNA
Level of the common deletion (in epidermis)
as percentage of total mtDNA
1 66 Head 0.06 0.62
2 68 Nose 0.17 0.28
3 68 Forehead 0.36 0.60
4 71 Retro auricular 0.00 0.03
5 74 Lower lip 0.01 0.25
6 78 Nose 0.15 1.09
7 82 Nose 0.84 3.15
8 89 Temple 0.98 0.92
9 91 Ear 0.03 0.17
10 91 Ear 0.09 0.22
11 91 Nose 0.16 0.28
12 91 Ear 0.05 0.08
13 91 Temple 0.08 0.30
14 91 Temple 0.02 0.15
15 97 Nose 0.31 0.54
16 97 Vertex 0.02 3.93
17 97 Head 0.09 0.12
18 56 Shoulder 0.01 0.01
19 73 Shoulder 0.09 0.13
20 75 Hip 1.15 0.60
mtDNA, mitochondrial DNA; SCC, squamous cell carcinoma.
There is no evidence for difference in relative levels of common deletion between age and gender of the patients.
Abbreviation: BCC, basal cell carcinoma; mtDNA, mitochondrial DNA; SCC, squamous cell carcinoma
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of the common deletion (Zhang et al.,
1992; Yang et al., 1994; Liu et al.,
1998). Besides this, it has been shown
that the common deletion can be
induced by UV irradiation in human
skin (Berneburg et al., 2004). Further-
more, skin cancer has been linked to
chronic UV exposure (Pang et al.,
1994). This link has been investigated
by Eshaghian et al. (2006) who pub-
lished data on mt deletions in basal cell
carcinoma (BCC) and squamous cell
carcinoma (SCC). They showed that
most of these tumors had lower or
undetectable amounts of mt deletions
compared to marginal non-tumor tis-
sue. However, there are methological
restrictions to this study. Although the
number of BCC was 25, the number of
investigated SCC tumors is considerably
low (four SCC investigated). Further-
more, the extraction method of tumor
and non-tumor tissue does not exclude
contamination by other tissues. Tumors
and margins were excised surgically
and examined histologically. As also
mentioned by the authors there is a
possibility, that extracted tumor sam-
ples contain a portion of non-tumor
tissue. This contamination makes the
distinction of mt deletions in tumor
tissue and non-tumor tissue difficult, as
unknown levels of non-tumor tissue
may also be present in tumor samples.
Furthermore, epidermal tissue was ana-
lyzed in a low portion of non-tumor
samples whereas the other samples
contained a mixture of epidermal and
dermal tissue whereas investigation
of only epidermal tissue would be
desirable.
Therefore, we initiated a study ap-
proved by the Department of Derma-
tology at the Eberhard Karls University,
Tu¨bingen, Germany and the local
ethics committee, similar to Eshaghian
et al., carrying out laser capture micro-
dissection to extract tumor cells and
epidermal cells from paraffin-em-
bedded histological samples. This al-
lows accurate isolation of tumor cells
avoiding contamination from tumor
surrounding stromal tissue. In addition,
tumor and epidermal cells from sam-
ples of 21 BCC and 20 SCC of patients
with different age and at different body
sites were isolated after histological
examination by laser capture micro-
dissection. As the level of the common
deletion can also be influenced by
chronological aging and UV exposure,
to exclude a bias of this non-tumor
specific influence on the common
deletion, levels of the common deletion
from tumor samples were normalized to
appropriate epidermal non-tumor tissue
of the same patient.
Detection of the common deletion
was carried out as described previously.
Table 2. Age and localization of 21 patients with BCC (sun exposed: head and face and upper extremities; non-sun
exposed: trunk and lower extremities)
Patient
(number)
Age of patients
(years) Localization
Level of the common deletion (in tumor)
as percentage of total mtDNA
Level of the common deletion (in epidermis)
as percentage of total mtDNA
1 49 Nose 0.06 1.87
2 51 Retro auricular 0.10 0.37
3 63 Forehead 0.00 0.00
4 65 Temple 0.04 2.04
5 70 Nose 0.04 0.31
6 70 Nose 0.44 2.86
7 70 Nose 1.46 5.00
8 71 Nose 0.17 0.07
9 73 Corner of the eye 1.08 1.18
10 73 Nose 0.03 1.10
11 74 Pre auricular 0.02 0.04
12 74 Retro auricular 0.11 0.35
13 75 Temple 0.05 3.92
14 79 Cheek 0.28 0.56
15 81 Cheek 0.24 0.16
16 81 Forehead 0.92 1.08
17 82 Nose 0.00 0.06
18 83 Lower palpebra 0.09 0.37
19 87 Temple 0.00 0.04
20 91 Pre auricular 0.11 0.14
21 64 Breast 0.01 0.06
BCC, basal cell carcinoma; mtDNA, mitochondrial DNA.
There is no evidence for difference in relative levels of the common deletion between age, gender of the patients.
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Briefly, after DNA extraction, levels of
the common deletion and undeleted
mtDNA sequences were detected with
real-time PCR as published (Koch et al.,
2001; Pfaffl, 2001). Levels of the com-
mon deletion in relation to surrounding
tissue are given as percentage of total
mtDNA.
RESULTS AND DISCUSSION
The common deletion could be de-
tected in 85.7% (18/21) BCC and 95%
(19/20) SCC and in all but one of the
non-tumor samples (Tables 1 and 2).
This is in accordance to the work by
Eshaghian et al. where in some samples
the common deletion was undetect-
able. It has been shown that the total
common deletion level present in most
tumor samples is low. However, it has
also been shown that the common
deletion accumulates during normal
aging. As skin tumors occur at higher
age, from our point of view, it is not
surprising that the common deletion
can be detected in most investigated
samples.
In our study, the common deletion
levels of SCC and BCC show similar
patterns as determined by real-time
PCR (Figures 1a and 2a) and confirmed
by agarose gel analysis of real-time PCR
results revealing only a single band for
the common deletion or the fragment
representing undeleted mtDNA (house-
keeping sequence) (Figures 1b and 2b).
The amount of the common deletion in
tumor cells taken together is signifi-
cantly lower than the common deletion
levels of epidermal cells (SCC:
P¼0.0005; BCC: P¼ 0.0005). In the
majority of SCC and BCC tumors, the
level of the common deletion is lower
than in corresponding non-tumor epi-
dermal tissue. Earlier findings have
shown that the level of the common
deletion can be induced by UV ex-
posure and chronological aging. These
effects must be considered when ex-
amining the level of the common
deletion in tumors of the patients and
comparing it to control tissue. Thus, it is
necessary to extract perilesional control
tissue near the tumor location to make
sure that the control tissue was exposed
to the same UV radiation and has the
same chronological age as the corre-
sponding tumor tissue in each patient.
Owing to our experimental design it is
not possible to differentiate between
aging or UV effects on the level of the
common deletion. Superimposing ef-
fects of age or UV irradiation on the
common deletion in control tissue can
only be ruled out if samples are taken
from the same location or patients have
the same age. Owing to the existing
cohort of patients and the fact that
patients with SCC or BCC tumors are
usually of relatively high age our data
did not reveal age-related changes of
the common deletion. This is in line
with results of other groups which also
failed to establish an age-related
change of the common deletion (Cor-
topassi et al., 1992; Koch et al., 2001).
Koch et al. (2001) suggested that mainly
donor variabilities are responsible for
different levels of the common deletion
in keratinocytes. Neither in SCC nor in
BCC an association between tumor size
and relative level of the common
deletion could be detected (data not
shown). Two BCC tumors and two SCC
tumors showed slightly increased levels
of the common deletion compared to
the corresponding non-tumor tissue.
But in these samples epidermal and
tumor tissue revealed low levels of the
common deletion (0.17 and 0.24%
common deletion in tumor probes and
0.07 and 0.16% in their corresponding
epidermal tissue) (Table 2) and the
difference between tumor and non-
tumor tissue in these samples is not
very high. In SCC two tumors showed a
slightly higher amount of the common
deletion (0.98% and 1.15% in tumor
probe) compared to non-tumor epider-
mal tissue (0.92 and 0.60%) (Table 1).
Thus, in our study the overall level of
the common deletion is reduced rather
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Figure 1. The levels of mitochondrial DNA common deletion are generally reduced in basal and
squamous cell carcinoma samples isolated by laser capture microdissection. (a) Levels of mtDNA
deletions in SCC and in surrounding epidermal non-tumor tissue. The level of the common deletion in
epidermal (black bars) and tumor tissue (gray bars) of different patients (1–20) with SCC is shown as
percentage of total mtDNA. In comparison to epidermal cells all SCC tumors together show significantly
lower levels of the common deletion (Wilcoxon test P-value¼ 0.0005). (b) Amplified DNA fragments
from patient 12 separated by agarose gel electrophoresis taken during log phase of the real-time PCR
reaction. Top panel: PCR fragment for the common deletion. Bottom panel: PCR fragment for
non-mutated mtDNA region serving as internal control (housekeeping sequence).
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than increased although higher or
similar amounts of the common dele-
tion can also be observed in single
cases.
In aggregate, our data support the
results by Eshaghian et al. in skin
tumors as well as the findings of
other groups in different tumor entities.
In an earlier study, BCC and SCC
tumors with higher levels of the com-
mon deletion as well tumors with low
levels of the common deletion were
observed (Durham et al., 2003). Dor-
mant status or low metabolism rates of
these BCC or SCC cells is also a
possible explanation why these cells
can afford higher levels of the common
deletion. Generally increased levels of
the common deletion seem to be an
exception. In many other carcinomas
(colorectal, breast, gastric, and head
and neck cancers) the common dele-
tion was reduced or almost absent
when compared to normal tissue
(Heerdt and Augenlicht, 1990; Fukush-
ima et al., 1995; Habano et al., 1998,
1999; Kotake et al., 1999; Angela
et al., 2004; Shieh et al., 2004). This
appears reasonable as dividing tumor
cells depend on abundant energy sup-
ply during proliferation. High levels of
the common deletion, implying that
approximately one-third of the mt
genome is missing, may lead to insuffi-
cient expression of mt proteins, thus
leading to an impaired respiratory
chain. Thus, defective energy produc-
tion and high levels of the common
deletion would preclude proliferation
in tumor cells.
Therefore, it is tempting to speculate
that a possible increase of the common
deletion, if it exists at all, is generally a
transient phenomenon during early
stages of carcinogenesis which disap-
pears at later stages of the tumor owing
to selection mechanisms for depletion
of the common deletion below the
level of progenitor cells. This could at
least explain the significantly lower
level of the common deletion in the
majority of tumor cells compared to
epidermal cells. Further work is needed
to undermine a potential role of the
common deletion as initial cancer
promoting factor as well as the exact
mechanisms responsible for possible
selection against high levels of large
mt deletions.
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The South African ‘‘Bathing Suit Ichthyosis’’ Is a Form
of Lamellar Ichthyosis Caused by a Homozygous
Missense Mutation, p.R315L, in Transglutaminase 1
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TO THE EDITOR
Recent years have seen considerable
advances in understanding the molecu-
lar basis of autosomal-recessive forms of
congenital ichthyosis. Indeed, mutations
in seven different genes and a further
two loci have been implicated. These
comprise TGM1 on 14q11.2 (Huber
et al., 1995), ALOX12B and ALOXE-3
on 17p13.1 (Jobard et al., 2002),
ABCA12 on 2q34 (Lefevre et al., 2003),
Ichthyin on 5q33 (Lefevre et al.,
2004), CGI-58 on 3p21 (Lefevre et al.,
2001), FLJ39501 on 19p12 (Lefevre
et al., 2006), and undisclosed genes on
12p11.2–q13 (Mizrachi-Koren et al.,
2005) and 19p13.1–p13.2 (Virolainen
et al., 2000). Nevertheless, cases of
autosomal-recessive congenital ichthyo-
sis display considerable clinical diversity
and some phenotypes may be striking
and unusual, perhaps indicating further
genetic heterogeneity. One such form of
autosomal-recessive congenital ichthyo-
sis is ‘‘badpak’’ or bathing suit ichthyosis
(BSI), a disorder that is found in parts of
South Africa. This condition was first
reported in the 1970s (Scott, 1972; Scott
and Lups, 1974) and further clinico-
pathological details have been published
recently (Jacyk, 2005). In brief, the
characteristic features consist of auto-
somal-recessive inheritance, skin ab-
normalities at birth (mainly collodion
babies), and large dark grey/brownish
scales affecting the trunk and scalp but
sparing the central face, buttocks, and
limbs. Palms and soles are dry and
diffusely mildly hyperkeratotic. The dor-
sal aspects of the hands and feet appear
normal and there are no nail abnormal-
ities. The main feature is the truncal
distribution of the ichthyosis which has
led to the colloquial term ‘‘bathing suit’’.
BSI may not be a uniquely South African
genodermatosis, but it has a remarkably
consistent phenotype within this popula-
tion (Scott, 1972; Scott and Lups, 1974;
Jacyk, 2005). Skin biopsies have shown
orthohyperkeratosis and acanthosis but
no discriminating findings (Jacyk, 2005).Abbreviation: BSI, bathing suit ichthyosis; SNP, single-nucleotide polymorphism
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